MedTrace Logo

Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases

NCT06520774 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2025-07-28

No results posted yet for this study

Summary

The objective of the study is to evaluate the safety and efficacy of the Lifetech Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases

Conditions

  • Aortic Arch Aneurysm
  • Penetrating Aortic Ulcer

Interventions

DEVICE

Concave Supra-arch Branched Stent-Graft System

To evaluate the efficacy and safety of Concave Supra-arch Branched Stent-Graft System for endovascular treatment of Aortic Arch Diseases

Sponsors & Collaborators

  • Second Xiangya Hospital of Central South University

    collaborator OTHER

  • Lifetech Scientific (Shenzhen) Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • chang shu, Professor · Second Xiangya Hospital of Central South University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-30
Primary Completion
2027-07-30
Completion
2031-06-30

Countries

  • China
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06520774 on ClinicalTrials.gov